Mark Massaro
Stock Analyst at BTIG
(4.39)
# 272
Out of 4,835 analysts
137
Total ratings
52.1%
Success rate
16.99%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Buy | $60 | $65.49 | -8.38% | 1 | Apr 21, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $9.05 | -0.55% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $56.42 | +32.93% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.79 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $7.93 | -11.73% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $4.95 | +41.41% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $163.04 | +38.00% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $152.59 | -11.53% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $1.03 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $68.31 | -34.12% | 4 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $40.67 | +22.94% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $518.10 | +11.95% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $8.11 | +158.94% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $2.30 | +247.83% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.60 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.09 | +282.78% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.96 | +170.27% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $16.75 | +79.10% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $6.01 | -16.81% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $17.54 | +42.53% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.33 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.26 | +177.78% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $2.79 | +3,484.23% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $83.62 | +258.77% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $56.81 | -11.98% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $177.97 | -37.07% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $249.52 | -33.87% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $33.46 | +139.09% | 9 | Sep 10, 2018 |
Tempus AI
Apr 21, 2025
Initiates: Buy
Price Target: $60
Current: $65.49
Upside: -8.38%
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $9.05
Upside: -0.55%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $56.42
Upside: +32.93%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.79
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $7.93
Upside: -11.73%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $4.95
Upside: +41.41%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $163.04
Upside: +38.00%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $152.59
Upside: -11.53%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.03
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $68.31
Upside: -34.12%
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $40.67
Upside: +22.94%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $518.10
Upside: +11.95%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $8.11
Upside: +158.94%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $2.30
Upside: +247.83%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.60
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.09
Upside: +282.78%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.96
Upside: +170.27%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $16.75
Upside: +79.10%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $6.01
Upside: -16.81%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $17.54
Upside: +42.53%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.33
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.26
Upside: +177.78%
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $2.79
Upside: +3,484.23%
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $83.62
Upside: +258.77%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $56.81
Upside: -11.98%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $177.97
Upside: -37.07%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $249.52
Upside: -33.87%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $33.46
Upside: +139.09%